Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

83 trials

NCT07821944
Recruiting
A Clinical Study of Enlicitide (MK-0616) in Adults With Hyperlipidemia in India (MK-0616-038)
Phase 3 · India · 2 sites
Registry update: 2 Nov 2026
NCT07473843
Recruiting
Study of Zodasiran in Adolescent Participants With Homozygous Familial Hypercholesterolemia
Phase 3 · Denmark, Netherlands, Norway, Poland, Sweden, United States · 6 sites
Registry update: 26 Oct 2026
2026-525917-29-00
Recruiting
Early TRIPLE versus dual LIPID lowering treatment in peOple with atherosclerotic cardiovascular disease and hypercholesterolemia Undergoing elecTive revascularisation
Phase 4 · Austria, Germany · 7 sites
Registry update: 17 Jul 2026
NCT07634484
Recruiting
A Post-Marketing Clinical Trial of Pemafibrate in Patients ｗith Hypercholesterolemia and Inadequate Response to Statins
Phase 4 · Japan · 10 sites
Registry update: 13 Jul 2026
NCT07428473
Recruiting
A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Phase 1 · Australia, New Zealand · 3 sites
Registry update: 21 Sept 2026
NCT07427472
Recruiting
"Detection and Follow-up of Coronary Lesions in HeFH (DESTINY-FH Study)"
Not applicable · France · 3 sites
Registry update: 24 Jun 2026
NCT07832578
Recruiting
Comparison of Aspirin Alone Versus Low-Dose Rivaroxaban Plus Aspirin in Chronic Limb-Threatening Ischemia
Early phase 1 · Pakistan · 1 site
Registry update: 22 Sept 2026
NCT07610278
Recruiting
A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
Phase 2 · United States · 27 sites
Registry update: 30 Jul 2026
NCT07524101
Recruiting
Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD
Not applicable · South Korea · 1 site
Registry update: 16 Jun 2026
NCT07591298
Recruiting
Phase II Clinical Trial to Evaluate the Efficacy and Safety of SYH2070 Injection in Participants With Homozygous Familial Hypercholesterolemia
Phase 2 · China · 1 site
Registry update: 31 Jul 2026
NCT07581808
Recruiting
Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention
Phase 4 · Slovenia · 1 site
Registry update: 2 Jun 2026
2025-523739-20-00
Recruiting
A Phase 3 Trial of K-924 HD in Participants with Hypercholesterolemia with Inadequate Response to EU-Marketed Pitavastatin 4 mg
Phase 3 · Spain · 8 sites
Registry update: 19 Jun 2026
NCT07614958
Recruiting
Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 Days
Phase 3 · United Kingdom · 1 site
Registry update: 9 Jun 2026
NCT07447648
Recruiting
Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)
Not applicable · France, Italy, Netherlands · 13 sites
Registry update: 21 Aug 2026
NCT07404553
Recruiting
A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors
Phase 2/3 · China · 1 site
Registry update: 16 Jun 2026
NCT07514663
Recruiting
Assessing the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile
Not applicable · United States · 1 site
Registry update: 17 Apr 2026
NCT07543731
Recruiting
A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab
Not applicable · Switzerland · 1 site
Registry update: 15 Jul 2026
NCT07465263
Recruiting
A Study to Evaluate the SYH2053 Injection in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
Phase 3 · China · 1 site
Registry update: 8 Jul 2026
NCT07206472
Recruiting
A Study of Bempedoic Acid or Its Single-pill Combination Therapy With Ezetimibe in Patients With Primary Hypercholesterolaemia or Mixed Dyslipidaemia
Not applicable · Brazil, Hong Kong, Thailand · 38 sites
Registry update: 19 Oct 2026
NCT07421297
Recruiting
A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia
Phase 3 · China · 1 site
Registry update: 7 Apr 2026

Ordered by registry start date. Freshness and sponsorship never change the order.